Mesa Laboratories Inc(MLAB)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
MLAB has no upcoming report date in the calendar yet. It last reported on Nov 9, 2026; companies usually report every three months.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±9.9%).
Did the stock rise after good news?
The next-day move after each of its last 4 EPS beats and 4 misses.
In plain words: it beat expectations 4 times, but the stock still fell 1 of those 4 times.
- Feb '26Beat▲ +8.7%
- Nov '25Beat▲ +1.5%
- Aug '25Missed▼ -24.9%
- May '25Missed▼ -8.9%
- Feb '25Missed▲ +2.5%
- Nov '24Beat▼ -12.1%
- Jun '24Missed▲ +13.2%
- Feb '24Beat▲ +5.6%
Clear beats and misses with a known reaction only. What counts as a beat
Why did MLAB fall after beating earnings?
3 of MLAB's last 8 reactions went against the EPS result. What stands out in each:
MLAB beat EPS estimates in 4 quarters, and the stock still closed lower the next day 1 time.
- Nov 7, 2024EPS beat +56.5%stock -12.1% next day
- It had risen 7.8% in the 20 trading sessions before the report, so good news may already have been priced in.
Rose despite an EPS miss (2 of 4)
- Feb 4, 2025EPS missed -47.7%stock +2.5% next day
- It had already fallen 4.0% in the final week before the report, so weak results may have been expected.
- It opened 1.2% higher as soon as trading resumed.
- Jun 5, 2024EPS missed -30.9%stock +13.2% next day
- It had already fallen 18.1% in the 20 trading sessions before the report, so weak results may have been expected.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was MLAB's earnings move already priced in?
MLAB's move in the month before each of its last 11 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 11 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does MLAB hold its opening gap after earnings?
MLAB's opening move after each report and where it closed that day.
In 8 reports MLAB opened at least 1% away from the previous close. It gave back half or more of that gap by the close 2 of 8 times (25%), and fully reversed 2 times. Gaps up faded 0 of 4; gaps down recovered 2 of 4.
- Nov 9, 2026HeldOpened +1.2%, closed +7.1%
- Aug 10, 2026ReversedOpened -3.4%, closed +9.5%
- Feb 3, 2026HeldOpened +3.1%, closed +8.7%
- Nov 6, 2025HeldOpened +1.3%, closed +1.5%
- Aug 5, 2025HeldOpened -2.1%, closed -24.9%
- May 28, 2025HeldOpened -2.1%, closed -8.9%
- Feb 4, 2025HeldOpened +1.2%, closed +2.5%
- Feb 5, 2024ReversedOpened -1.6%, closed +5.6%
MLAB earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | Revenue surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | After close | $2.24 | $1.71 | sources differ | -1.7% | +7.11% | — |
| Aug 10, 2026 | After close | $2.55 | $1.30 | sources differ | — | +9.46% | +11.40% |
| May 27, 2026 | Before open | $1.39 | $1.83 | sources differ | — | -14.48% | -3.91% |
| Feb 3, 2026 | Before open | $1.47 | $1.76 | +19.7% | — | +8.73% | +13.29% |
| Nov 6, 2025 | After close | $1.56 | $2.11 | +35.3% | — | +1.52% | +6.92% |
| Aug 5, 2025 | Before open | $2.16 | $1.88 | -13.0% | — | -24.92% | -17.03% |
| May 28, 2025 | Before open | $2.07 | $0.43 | -79.2% | — | -8.95% | -11.11% |
| Feb 4, 2025 | Before open | $1.51 | $0.79 | -47.7% | — | +2.49% | +5.82% |
| Nov 7, 2024 | Before open | $1.38 | $2.16 | +56.5% | — | -12.13% | -11.34% |
| Aug 5, 2024 | Before open | $1.55 | $1.96 | +26.5% | — | — | — |
| Jun 5, 2024 | Before open | $1.75 | $1.21 | -30.9% | — | +13.15% | +10.62% |
| Feb 5, 2024 | Before open | $1.70 | $2.62 | +54.1% | — | +5.64% | -3.60% |
MLAB Earnings FAQ
Answers computed from Mesa Laboratories Inc's reported history
MLAB has no upcoming report date in the calendar yet. It last reported on Nov 9, 2026; companies usually report every three months.
Over the last 9 quarters with a usable EPS surprise, MLAB beat the consensus estimate 5 times (56%), missed 4 and landed in line 0. It has beaten estimates in each of the last 2 counted quarters. 3 quarters where our data sources disagree on beat versus miss are shown but not counted.
Across its last 11 quarters with a measured reaction, MLAB moved an average of ±9.9% in the first session after reporting. It closed higher 64% of the time; the largest gain was 13.2% and the largest drop -24.9%.
MLAB fell in the first session after 1 of its last 4 EPS beats (25%). A beat that was already priced in, or weaker guidance, can send a stock lower.
Across its last 11 quarters with price data, MLAB moved an average of -1.4% in the 20 trading sessions before reporting and was higher in 55% of them. After a run-up of 3% or more (4 quarters), it fell the next day 50% of the time, averaging -3.9%. After a drop of 3% or more (4 quarters), it rose the next day 50% of the time, averaging -3.8%. This describes past reports; it is not a forecast.
In 8 reports MLAB opened at least 1% away from the previous close. It gave back half or more of that gap by the close 2 of 8 times (25%), and fully reversed 2 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · MLAB: 12 reported quarters, latest Nov 9, 2026. Information only, not investment advice.
Looking for more on MLAB?
Price charts, forecast, fundamentals and risk pages for MLAB are not on Tickzen yet. You can run a full stock analysis now.
Run the MLAB Stock AnalyzerLatest TickZen Insights
AbbVie (ABBV) Q3 2026 Earnings Preview: Will Skyrizi and Rinvoq be able to justify the 20x?By Vishal Jadaun
Alphabet (GOOG) Q3 2026 Earnings Preview: Will Cloud Overtake Capex?By Vishal Jadaun
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun